Μετάβαση στο περιεχόμενο

Ετικέταacute myeloid leukemia

Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

  Shares of Agios Pharmaceuticals jumped this morning after the Cambridge, Mass.-based company said the U.S.Food and Drug Administration (FDA) approved its oral leukemia treatment Tibsovo (ivosidenib). It’s the second approval for the company in … Continue Reading Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

MB-102

CD123 is a subunit of the heterodimeric interleukin-3-receptor (IL-3R) which is widely expressed on human hematologic malignancies including acute myeloid leukemia (AML).   In addition, CD123 can be found on the … Continue Reading MB-102